AMANDA WU: Open Payments
NPI 1497754014 · OLDSMAR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 31 payments from 8 companies in 2025. Trend: 2023 $1,107 · 2024 $1,260 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $280 |
| GlaxoSmithKline, LLC. | 10 | $242 |
| AstraZeneca Pharmaceuticals LP | 7 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $64 |
| Amgen Inc. | 2 | $33 |
| Lilly USA, LLC | 1 | $30 |
| Avvisto Therapeutics, LLC | 1 | $20 |
| Phadia US Inc. | 1 | $16 |
Products named: Kerendia, TRELEGY ELLIPTA, FARXIGA, JARDIANCE, OTEZLA, KISUNLA, CYCLOSET, ImmunoCAP.
Industry payments across FL — which companies pay providers there.
